Echelon Biosciences was formed from a project under the Center for Cell Signaling, a State of Utah Center of Excellence, and was incorporated under the laws of the state of Utah as Echelon Research Laboratories, Inc. on October 3, 1997. The company has since changed its name to Echelon Biosciences Incorporated. The company was organized to further the science of lipid cell signaling and critical metabolic enzymes, which provide new and viable targets for the development of potential drugs and diagnostics for cancer, diabetes, inflammation, infections, and cardiovascular disease.
Echelon Biosciences
675 Arapeen Drive, Suite 302
Salt Lake City
UT
84108
801-588-0455
Deal Flow
Fundings
Mergers & Acquisitions
| Closing Date | Acquiree | Amount |
|---|---|---|
| 05/01/2006 | Echelon Biosciences | $3,200,000 |
Public Offerings
Company Snapshot
Yes
Biotechnology | Therapeutics
Acquired
Generating Revenue
$140,000,000
240
240
Echelon was founded in Utah and acquired by Frontier Scientific in 2007.
Key People
-
Paul Neilsen
Director of R&D and Manufacturing and PHd
-
James Thompson
Director of New Product Development, MSc
-
W. Tim Miller
CEO and President






